ATE212227T1 - Verwendung von kompocedinderivaten zur inhibierung der bildung oder sekretion von beta- amyloid-protein - Google Patents
Verwendung von kompocedinderivaten zur inhibierung der bildung oder sekretion von beta- amyloid-proteinInfo
- Publication number
- ATE212227T1 ATE212227T1 AT96901960T AT96901960T ATE212227T1 AT E212227 T1 ATE212227 T1 AT E212227T1 AT 96901960 T AT96901960 T AT 96901960T AT 96901960 T AT96901960 T AT 96901960T AT E212227 T1 ATE212227 T1 AT E212227T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- optionally substituted
- secretion
- date
- compocedine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2668795 | 1995-02-15 | ||
PCT/JP1996/000265 WO1996025161A1 (en) | 1995-02-15 | 1996-02-08 | Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE212227T1 true ATE212227T1 (de) | 2002-02-15 |
Family
ID=12200316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96901960T ATE212227T1 (de) | 1995-02-15 | 1996-02-08 | Verwendung von kompocedinderivaten zur inhibierung der bildung oder sekretion von beta- amyloid-protein |
Country Status (11)
Country | Link |
---|---|
US (1) | US5965568A (de) |
EP (1) | EP0813411B1 (de) |
AT (1) | ATE212227T1 (de) |
AU (1) | AU4632996A (de) |
CA (1) | CA2213094A1 (de) |
DE (1) | DE69618765T2 (de) |
DK (1) | DK0813411T3 (de) |
ES (1) | ES2171646T3 (de) |
HU (1) | HUP9801155A3 (de) |
PT (1) | PT813411E (de) |
WO (1) | WO1996025161A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6229699A (en) * | 1998-10-26 | 2000-05-15 | Sumitomo Pharmaceuticals Company, Limited | Beta-amyloid formation inhibitors |
EP1355669B1 (de) * | 2000-08-10 | 2011-09-28 | Cold Spring Harbor Laboratory | Gesteigertes kognitives training |
US8153646B2 (en) * | 2000-08-10 | 2012-04-10 | Dart Neuroscience (Cayman) Ltd. | Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
JP2006516150A (ja) * | 2002-11-22 | 2006-06-22 | ノバルティス アクチエンゲゼルシャフト | アルツハイマー病の処置法およびそのための組成物 |
BR0318588A (pt) * | 2003-10-28 | 2006-10-17 | Univ Mexico Nacional Autonoma | uso da vinpocetina para prevenir as complicações, particularmente as relacionadas à audição, que acompanham a epilepsia e seu tratamento |
GB0329498D0 (en) * | 2003-12-19 | 2004-01-28 | Novartis Ag | Organic compounds |
US20080021016A1 (en) * | 2004-03-12 | 2008-01-24 | Levay Gyoergy | Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions |
JP5160764B2 (ja) * | 2006-10-13 | 2013-03-13 | 全薬工業株式会社 | 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤 |
KR101095026B1 (ko) * | 2009-01-23 | 2011-12-20 | 한국과학기술연구원 | 비스(스티릴)피리미딘 및 비스(스티릴)벤젠 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 베타아밀로이드 집적 관련 질환의 예방 또는 치료용 약학적 조성물 |
WO2010103539A2 (en) | 2009-03-09 | 2010-09-16 | Dinesh Shantilal Patel | Sustained release oral formulation of vinpocetine |
CN102875547B (zh) * | 2011-07-15 | 2015-05-27 | 海南灵康制药有限公司 | 一种长春西汀化合物及其制法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4035370A (en) * | 1971-11-03 | 1977-07-12 | Richter Gedeon Vegyeszeti Gyar Rt. | Alkaloid esters |
HU181941B (en) * | 1979-11-23 | 1983-11-28 | Richter Gedeon Vegyeszet | Process for producing apovincaminic acid ester derivatives |
HU201674B (en) * | 1987-08-26 | 1990-12-28 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition suitable for curing autoimmune-type leukoencephalomyelitic diseases e.g. sclerosis multiplex |
JPH02167279A (ja) * | 1988-09-30 | 1990-06-27 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
JPH02152979A (ja) * | 1988-12-06 | 1990-06-12 | Taisho Pharmaceut Co Ltd | アポビンカミン酸誘導体 |
JPH02204488A (ja) * | 1989-02-03 | 1990-08-14 | Taisho Pharmaceut Co Ltd | エブルナメニン誘導体 |
JP3053913B2 (ja) * | 1991-07-15 | 2000-06-19 | 帝三製薬株式会社 | ビンポセチン類含有貼付剤 |
US5296478A (en) * | 1992-10-07 | 1994-03-22 | The Dupont Merck Pharmaceutical Co. | 1-substituted oxindoles as cognition enhancers |
EP0683234B2 (de) * | 1993-01-25 | 2007-06-06 | Takeda Chemical Industries, Ltd. | Antikörper gegen beta-amyloid oder derivative davon und seine verwendung |
-
1996
- 1996-02-08 PT PT96901960T patent/PT813411E/pt unknown
- 1996-02-08 WO PCT/JP1996/000265 patent/WO1996025161A1/en active IP Right Grant
- 1996-02-08 CA CA002213094A patent/CA2213094A1/en not_active Abandoned
- 1996-02-08 AU AU46329/96A patent/AU4632996A/en not_active Abandoned
- 1996-02-08 DK DK96901960T patent/DK0813411T3/da active
- 1996-02-08 HU HU9801155A patent/HUP9801155A3/hu unknown
- 1996-02-08 DE DE69618765T patent/DE69618765T2/de not_active Expired - Fee Related
- 1996-02-08 AT AT96901960T patent/ATE212227T1/de not_active IP Right Cessation
- 1996-02-08 ES ES96901960T patent/ES2171646T3/es not_active Expired - Lifetime
- 1996-02-08 US US08/646,354 patent/US5965568A/en not_active Expired - Fee Related
- 1996-02-08 EP EP96901960A patent/EP0813411B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU4632996A (en) | 1996-09-04 |
EP0813411A1 (de) | 1997-12-29 |
WO1996025161A1 (en) | 1996-08-22 |
DE69618765T2 (de) | 2002-10-17 |
HUP9801155A2 (hu) | 1998-09-28 |
DE69618765D1 (de) | 2002-03-14 |
DK0813411T3 (da) | 2002-05-13 |
US5965568A (en) | 1999-10-12 |
PT813411E (pt) | 2002-07-31 |
EP0813411B1 (de) | 2002-01-23 |
CA2213094A1 (en) | 1996-08-22 |
HUP9801155A3 (en) | 1999-03-01 |
ES2171646T3 (es) | 2002-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9804107A (es) | Derivados de quinolina. | |
DE69839305D1 (de) | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta | |
IE802612L (en) | Bicyclo £2.2.1| heptane derivatives | |
BG100656A (en) | Derivatives of naphthalene, method and intermediate compounds for their preparation | |
ATE212227T1 (de) | Verwendung von kompocedinderivaten zur inhibierung der bildung oder sekretion von beta- amyloid-protein | |
EP0703222A4 (de) | 3-aminoazepin-verbindung und ihre pharmazeutische verwendung | |
IL113778A0 (en) | Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof | |
ES8801290A1 (es) | Un metodo para preparar derivados de cefem | |
HUT67283A (en) | Method for producing n-containing fused heterocyclic ketone derivatives and medical preparatives containing them | |
HUP9904594A2 (hu) | Piperazinoszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ES8606880A1 (es) | Un procedimiento para la preparacion de nuevos peptidos. | |
SE8303913L (sv) | Heterocykliska foreningar | |
NO955328D0 (no) | Pyridazin-derivater | |
UA26459C2 (uk) | Іhгібітор впливу амілоїдhих білків | |
DE3674372D1 (de) | 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
AU539177B2 (en) | Amino alkoxy pyrazoles | |
ATE27455T1 (de) | Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. | |
AU4583489A (en) | New indole derivatives, process for preparing them and pharmaceutical compositions containing them | |
ES2010225A6 (es) | Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6. | |
RU95110868A (ru) | Новые конденсированные производные тиазола, способ его получения и его фармацевтическая композиция | |
EP0160969A3 (de) | Cephemverbindungen | |
AU586255B2 (en) | Substituted pyridine-1-oxides | |
IE881752L (en) | New aminoacylates of glycerol acetal | |
MX9710378A (es) | Derivados de 4-finilaminotiazol, su proceso de preparacion y las composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEIH | Change in the person of patent owner | ||
UEP | Publication of translation of european patent specification |
Ref document number: 0813411 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |